Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Margolin

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Cancer Chemotherapy and Pharmacology|June 3, 2004
Feasibility and pharmacokinetic study of infusional dexrazoxane and dose-intensive doxorubicin administered concurrently over 96 h for the treatment of advanced malignanciesWarren A Chow, Timothy W Synold, Merry L Tetef, et al.
Cancer Chemotherapy and Pharmacology|June 9, 2004
Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancerRobert J Morgan, Timothy W Synold, David Gandara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2003
SU5416 plus interferon alpha in advanced renal cell carcinoma: a phase II California Cancer Consortium Study with biological and imaging correlates of angiogenesis inhibitionPrimo N Lara, David I Quinn, Kim Margolin, et al.
Journal of Translational Medicine|November 7, 2012
A novel series of conferences tackling the hurdles confronting the translation of novel cancer immunotherapiesAdrian Bot, Mark Ahn, Marnix Bosch, et al.
Pigment Cell & Melanoma Research|January 10, 2020
Leptomeningeal disease in melanoma patients: An update to treatment, challenges, and future directionsIsabella C Glitza, Keiran S M Smalley, Priscilla K Brastianos, et al.
Cancer Journal (Sudbury, Mass.)|January 22, 2014
A single-arm, open-label, expanded access study of vemurafenib in patients with metastatic melanoma in the United StatesLawrence Flaherty, Omid Hamid, Gerald Linette, et al.
JCI Insight|February 8, 2022
Tumor-infiltrating exhausted CD8+ T cells dictate reduced survival in premenopausal estrogen receptor-positive breast cancerColt A Egelston, Weihua Guo, Jiayi Tan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2018
Phase I Trial of ALT-803, A Novel Recombinant IL15 Complex, in Patients with Advanced Solid TumorsKim Margolin, Chihiro Morishima, Vamsidhar Velcheti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2007
Phase I trial of intraperitoneal gemcitabine in the treatment of advanced malignancies primarily confined to the peritoneal cavityRobert J Morgan, Timothy W Synold, Bixin Xi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2025
Comparative Analysis of Intracranial Response Assessment Criteria in Patients With Melanoma Brain Metastases Treated With Combination Nivolumab + Ipilimumab in CheckMate 204Raymond Y Huang, Gilbert Youssef, Thomas Nelson, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Cancer Chemotherapy and Pharmacology|June 3, 2004
Feasibility and pharmacokinetic study of infusional dexrazoxane and dose-intensive doxorubicin administered concurrently over 96 h for the treatment of advanced malignanciesWarren A Chow, Timothy W Synold, Merry L Tetef, et al.
Cancer Chemotherapy and Pharmacology|June 9, 2004
Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancerRobert J Morgan, Timothy W Synold, David Gandara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2003
SU5416 plus interferon alpha in advanced renal cell carcinoma: a phase II California Cancer Consortium Study with biological and imaging correlates of angiogenesis inhibitionPrimo N Lara, David I Quinn, Kim Margolin, et al.
Journal of Translational Medicine|November 7, 2012
A novel series of conferences tackling the hurdles confronting the translation of novel cancer immunotherapiesAdrian Bot, Mark Ahn, Marnix Bosch, et al.
Pigment Cell & Melanoma Research|January 10, 2020
Leptomeningeal disease in melanoma patients: An update to treatment, challenges, and future directionsIsabella C Glitza, Keiran S M Smalley, Priscilla K Brastianos, et al.
Cancer Journal (Sudbury, Mass.)|January 22, 2014
A single-arm, open-label, expanded access study of vemurafenib in patients with metastatic melanoma in the United StatesLawrence Flaherty, Omid Hamid, Gerald Linette, et al.
JCI Insight|February 8, 2022
Tumor-infiltrating exhausted CD8+ T cells dictate reduced survival in premenopausal estrogen receptor-positive breast cancerColt A Egelston, Weihua Guo, Jiayi Tan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2018
Phase I Trial of ALT-803, A Novel Recombinant IL15 Complex, in Patients with Advanced Solid TumorsKim Margolin, Chihiro Morishima, Vamsidhar Velcheti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2007
Phase I trial of intraperitoneal gemcitabine in the treatment of advanced malignancies primarily confined to the peritoneal cavityRobert J Morgan, Timothy W Synold, Bixin Xi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2025
Comparative Analysis of Intracranial Response Assessment Criteria in Patients With Melanoma Brain Metastases Treated With Combination Nivolumab + Ipilimumab in CheckMate 204Raymond Y Huang, Gilbert Youssef, Thomas Nelson, et al.
Pageof 10